Caspofungin as treatment for Candida glabrata hip infection

被引：25
|
作者：
Lejko-Zupanc, T
Mozina, E
Vrevc, F
机构：
[1] Med Ctr Ljubljana, Dept Infect Dis, Ljubljana 1000, Slovenia
[2] Med Ctr Ljubljana, Inst Radiol, Ljubljana 1000, Slovenia
[3] Med Ctr Ljubljana, Dept Orthopaed Surg, Ljubljana 1000, Slovenia
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2005年 / 25卷 / 03期
关键词：
D O I：
10.1016/j.ijantimicag.2005.01.005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [11] Candida glabrata endophthalmitis treated successfully with caspofungin.
    Bradley, JC
    Mitchell, KT
    Kimbrough, RC
    Vidal, AM
    Sarria, JC
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S279 - S279
  • [12] Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection
    Thompson, George R., III
    Wiederhold, Nathan P.
    Vallor, Ana C.
    Villareal, Nyria C.
    Lewis, James S., II
    Patterson, Thomas F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) : 3783 - 3785
  • [13] Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility
    Brzankalski, Gabriela E.
    Najvar, Laura K.
    Wiederhold, Nathan P.
    Bocanegra, Rosie
    Fothergill, Annette W.
    Rinaldi, Michael G.
    Pattterson, Thomas F.
    Graybill, John R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 1094 - 1100
  • [14] Caspofungin/immunosuppressantsCandida glabrata infection and acquired caspofungin resistance: case report
    Reactions Weekly, 2020, 1788 (1) : 71 - 71
  • [15] Candida glabrata infection following total hip arthroplasty: A case report
    Zhu, Yun
    Yue, Chen
    Huang, Zeyu
    Pei, Fuxing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (02) : 352 - 354
  • [16] Caspofungin/voriconazoleDevelopment of resistance in Candida glabrata and Candida lusitaniae: 2 case reports
    Reactions Weekly, 2017, 1641 (1) : 62 - 62
  • [17] Efficacy of caspofungin, fluconazole and micafungin for the treatment of the infection caused by Candida glabrata complex in the non-conventional model Caenorhabditis elegans
    Hernando, A.
    Ortega-Riveros, M.
    de la Pinta, I.
    Eraso, E.
    Quindos, G.
    MYCOSES, 2015, 58 : 87 - 88
  • [18] Cellular apoptosis: an alternative mechanism of action of caspofungin in Candida glabrata
    Moazeni, M.
    Aryamloo, P.
    Asgarian-Omran, H.
    Shokohi, T.
    Badali, H.
    Hossein-Nataj, H.
    Aslani, N.
    Nabili, M.
    Gohar, A. Abdollahi
    MEDICAL MYCOLOGY, 2018, 56 : S43 - S43
  • [19] Assessment of the In Vitro Kinetic Activity of Caspofungin against Candida glabrata
    Nagappan, V.
    Boikov, D.
    Vazquez, J. A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 522 - 525
  • [20] In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm
    Pesee, Siripen
    Angkananuwat, Chayanit
    Tancharoensukjit, Sudarat
    Muanmai, Somporn
    Sirivan, Pattaraporn
    Bubphawas, Manita
    Tanarerkchai, Nissara
    MEDICAL MYCOLOGY, 2016, 54 (04) : 384 - 393
12345